What question did this study set out to answer?

The aim is to explore the role of irisin as a biomarker in assessing metabolic differences between hyperandrogenic and normoandrogenic PCOS phenotypes.

April 15, 2026

Unveiling the Role of Irisin as a Biomarker in Adolescent and Young Adult PCOS : A Metabolic and Hormonal Comparison of Hyperandrogenic and Normoandrogenic Phenotypes

Key Points

The aim is to explore the role of irisin as a biomarker in assessing metabolic differences between hyperandrogenic and normoandrogenic PCOS phenotypes.
Comparison of metabolic and hormonal profiles between HA-PCOS and normoandrogenic PCOS.
Assessment of irisin levels in adolescents and young adults with PCOS.
Evaluation of long-term complications associated with metabolic disruption.
HA-PCOS is associated with more significant metabolic disruptions than normoandrogenic PCOS.
Irisin levels may indicate severity of metabolic issues in HA-PCOS.
Irisin could help in predicting long-term health complications related to PCOS.

Abstract

HA-PCOS is marked by more severe metabolic disruption. Irisin may serve as a promising early biomarker for this phenotype and help predict long-term complications linked to metabolic disruption in PCOS.

Unveiling the Role of Irisin as a Biomarker in Adolescent and Young Adult PCOS : A Metabolic and Hormonal Comparison of Hyperandrogenic and Normoandrogenic Phenotypes

Key Points

Abstract

Cite This Study

Also Consider

Also Consider